← Back to patent-cliff list
Levothyroxine Sodium/Liothyronine sodium
Tier C — Watch / tradeLevothyroxine Sodium/Liothyronine sodium
Dorsa Pharmaceutical Company
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：THR, THRB, THRA
Indications (approved)：Hypothyroidism
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Levothyroxine Sodium/Liothyronine sodium?
Approved indications include: Hypothyroidism.
When does the Levothyroxine Sodium/Liothyronine sodium patent expire?
No public expiry year is available for Levothyroxine Sodium/Liothyronine sodium yet; this page updates once verified.
How do I get a quote for Levothyroxine Sodium/Liothyronine sodium intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-05